Literature DB >> 582089

Alkaline phosphatase isoenzyme patterns in hyperthyroidism.

D S Cooper, M M Kaplan, E C Ridgway, F Maloof, G H Daniels.   

Abstract

Fifteen of 36 hyperthyroid patients had elevation in serum alkaline phosphatase activity. There was no difference in mean thyroxine (T4), triiodothyronine (T3), age, or duration of illness between the groups with high alkaline phosphatase and normal alkaline phosphatase levels. After treatment, serum alkaline phosphatase levels rose as T4 levels declined; at 3 months, the mean serum alkaline phosphatase value rose from 7.1 Bodansky units to 10.3 Bodansky units (P less than 0.005), while the mean T4 value fell from 18 microgram/dl to 7.2 microgram/dl (P less than 0.005). In some patients, serum alkaline phosphatase values have remained elevated for more than 1 year, despite continued normality in thyroid variables. Before therapy, isoenzyme patterns analyzed by polyacrylamide gel electrophoresis were qualitatively normal. As therapy was instituted, the isoenzyme patterns changed markedly, with increased amounts of bone alkaline phosphatase appearing in the serum as T4 levels were declining and total alkaline phosphatase was rising. Thyroid tissue homogenates from patients with Graves' disease were found to have very low levels of alkaline phosphatase activity and an isoenzyme pattern quite distinct from that found in the serum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582089     DOI: 10.7326/0003-4819-90-2-164

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Resolution of propylthiouracil-induced hepatic failure after treatment of thyrotoxicosis.

Authors:  W Khovidhunkit; R V Farese
Journal:  West J Med       Date:  1997-11

Review 2.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis.

Authors:  G Babini; L Gurioli; R Rizzi; P Bertello
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Bone mineralization and calciotropic hormones in children with hyperthyroidism. Effects of methimazole therapy.

Authors:  G Saggese; S Bertelloni; G I Baroncelli
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

5.  Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism.

Authors:  N Kobe; J Takamatsu; M Ito; S Sakane; N Ohsawa
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.633

6.  Alkaline phosphatase bone isoenzyme and osteocalcin in the serum of hyperthyroid cats.

Authors:  F J Archer; S M Taylor
Journal:  Can Vet J       Date:  1996-12       Impact factor: 1.008

7.  The effects of recombinant human TSH on bone turnover in patients after thyroidectomy.

Authors:  Helen Karga; Garyphallia Papaioannou; Antonis Polymeris; Konstantinos Papamichael; Angeliki Karpouza; Elizabeth Samouilidou; Panayotis Papaioannou
Journal:  J Bone Miner Metab       Date:  2009-06-23       Impact factor: 2.626

8.  Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves' disease as compared to toxic nodular goiter.

Authors:  H Czernobilsky; S Scharla; H Schmidt-Gayk; R Ziegler
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

9.  Hyperthyroidism and jaundice.

Authors:  Cs Bal; Madhavi Chawla
Journal:  Indian J Nucl Med       Date:  2010-10

Review 10.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.